105 related articles for article (PubMed ID: 19243496)
21. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.
Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R
J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587
[TBL] [Abstract][Full Text] [Related]
22. Hsp90 inhibitors suppress HCV replication in replicon cells and humanized liver mice.
Nakagawa S; Umehara T; Matsuda C; Kuge S; Sudoh M; Kohara M
Biochem Biophys Res Commun; 2007 Feb; 353(4):882-8. PubMed ID: 17196931
[TBL] [Abstract][Full Text] [Related]
23. Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system.
Kato T; Date T; Miyamoto M; Sugiyama M; Tanaka Y; Orito E; Ohno T; Sugihara K; Hasegawa I; Fujiwara K; Ito K; Ozasa A; Mizokami M; Wakita T
J Clin Microbiol; 2005 Nov; 43(11):5679-84. PubMed ID: 16272504
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin a, on interferon-induced antiviral protein in human hepatocyte cells.
Hirano K; Ichikawa T; Nakao K; Matsumoto A; Miyaaki H; Shibata H; Eguchi S; Takatsuki M; Ikeda M; Yamasaki H; Kato N; Kanematsu T; Ishii N; Eguchi K
Liver Transpl; 2008 Mar; 14(3):292-8. PubMed ID: 18306331
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of the interferon alpha response against hepatitis C virus replicons.
Guo JT; Sohn JA; Zhu Q; Seeger C
Virology; 2004 Jul; 325(1):71-81. PubMed ID: 15231387
[TBL] [Abstract][Full Text] [Related]
26. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes.
Watashi K; Hijikata M; Hosaka M; Yamaji M; Shimotohno K
Hepatology; 2003 Nov; 38(5):1282-8. PubMed ID: 14578868
[TBL] [Abstract][Full Text] [Related]
27. Targeting cellular squalene synthase, an enzyme essential for cholesterol biosynthesis, is a potential antiviral strategy against hepatitis C virus.
Saito K; Shirasago Y; Suzuki T; Aizaki H; Hanada K; Wakita T; Nishijima M; Fukasawa M
J Virol; 2015 Feb; 89(4):2220-32. PubMed ID: 25473062
[TBL] [Abstract][Full Text] [Related]
28. New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1.
Taylor DR; Puig M; Darnell ME; Mihalik K; Feinstone SM
J Virol; 2005 May; 79(10):6291-8. PubMed ID: 15858013
[TBL] [Abstract][Full Text] [Related]
29. Acetylsalicylic acid inhibits hepatitis C virus RNA and protein expression through cyclooxygenase 2 signaling pathways.
Trujillo-Murillo K; Rincón-Sánchez AR; Martínez-Rodríguez H; Bosques-Padilla F; Ramos-Jiménez J; Barrera-Saldaña HA; Rojkind M; Rivas-Estilla AM
Hepatology; 2008 May; 47(5):1462-72. PubMed ID: 18393288
[TBL] [Abstract][Full Text] [Related]
30. Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha.
Tanabe Y; Sakamoto N; Enomoto N; Kurosaki M; Ueda E; Maekawa S; Yamashiro T; Nakagawa M; Chen CH; Kanazawa N; Kakinuma S; Watanabe M
J Infect Dis; 2004 Apr; 189(7):1129-39. PubMed ID: 15031779
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of hepatitis C virus replication by Monascus pigment derivatives that interfere with viral RNA polymerase activity and the mevalonate biosynthesis pathway.
Sun JM; Kim SJ; Kim GW; Rhee JK; Kim ND; Jung H; Jeun J; Lee SH; Han SH; Shin CS; Oh JW
J Antimicrob Chemother; 2012 Jan; 67(1):49-58. PubMed ID: 22076990
[TBL] [Abstract][Full Text] [Related]
32. Interference with ERK and STAT signaling pathways and inhibition of hepatitis C virus replication by ribavirin.
Zhao LJ; Wang W; Liu Y; Ren H; Qi ZT
Antiviral Res; 2012 Nov; 96(2):260-8. PubMed ID: 22985631
[TBL] [Abstract][Full Text] [Related]
33. Ribavirin up-regulates the activity of double-stranded RNA-activated protein kinase and enhances the action of interferon-alpha against hepatitis C virus.
Liu WL; Su WC; Cheng CW; Hwang LH; Wang CC; Chen HL; Chen DS; Lai MY
J Infect Dis; 2007 Aug; 196(3):425-34. PubMed ID: 17597457
[TBL] [Abstract][Full Text] [Related]
34. Protein kinase C-related kinase 2 regulates hepatitis C virus RNA polymerase function by phosphorylation.
Kim SJ; Kim JH; Kim YG; Lim HS; Oh JW
J Biol Chem; 2004 Nov; 279(48):50031-41. PubMed ID: 15364941
[TBL] [Abstract][Full Text] [Related]
35. Hydroxyurea as an inhibitor of hepatitis C virus RNA replication.
Nozaki A; Morimoto M; Kondo M; Oshima T; Numata K; Fujisawa S; Kaneko T; Miyajima E; Morita S; Mori K; Ikeda M; Kato N; Tanaka K
Arch Virol; 2010 Apr; 155(4):601-5. PubMed ID: 20204428
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.
Okuse C; Rinaudo JA; Farrar K; Wells F; Korba BE
Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968
[TBL] [Abstract][Full Text] [Related]
37. Anti-hepatitis C virus RdRp activity and replication of novel anilinobenzothiazole derivatives.
Peng HK; Chen WC; Lin YT; Tseng CK; Yang SY; Tzeng CC; Lee JC; Yang SC
Antiviral Res; 2013 Oct; 100(1):269-75. PubMed ID: 23994188
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of subgenomic hepatitis C virus RNA replication in HeLa cells.
Kanda T; Yokosuka O; Mikata R; Zhang KY; Tanaka M; Tada M; Fukai K; Imazeki F; Saisho H
Hepatogastroenterology; 2007; 54(73):32-5. PubMed ID: 17419226
[TBL] [Abstract][Full Text] [Related]
39. NIM811, a cyclophilin inhibitor, exhibits potent in vitro activity against hepatitis C virus alone or in combination with alpha interferon.
Ma S; Boerner JE; TiongYip C; Weidmann B; Ryder NS; Cooreman MP; Lin K
Antimicrob Agents Chemother; 2006 Sep; 50(9):2976-82. PubMed ID: 16940091
[TBL] [Abstract][Full Text] [Related]
40. Mizoribine inhibits hepatitis C virus RNA replication: effect of combination with interferon-alpha.
Naka K; Ikeda M; Abe K; Dansako H; Kato N
Biochem Biophys Res Commun; 2005 May; 330(3):871-9. PubMed ID: 15809077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
